K

Kojin Therapeutics

24 employees

Kojin is a biopharmaceutical company that develops new targeted therapeutics based on cell state and ferroptosis biology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical
Biopharma
Life Science

Date founded

2020

Funding rounds raised

Total raised

$60M

from 5 investors over 5 rounds

K

Kojin Therapeutics raised $60M on June 9, 2021

Investors: Newpath Partners, Leaps by Bayer, Eventide Asset Management, Cathay Capital and Polaris Partners

FAQ